Call for entries for the Dr John Hinds Scholarship

02 March 2020 | Galen | News

More News

The Pharma Letter: Galen sticking to its principles as it embarks on ambitious future

07 March 2024 | Galen | News

Galen announces exclusive licensing agreement with Italfarmaco for the distribution of Cariban® (doxylamine/pyridoxine) in Ireland for nausea and vomiting in pregnancy

31 July 2024 | Galen | News

POA Pharma, enters the German market, securing exclusive in-licensing rights for Rapilose Oral Glucose Solution (OGS)

19 September 2022 | News

Would you like to discuss how Galen can help you?

If you would like to explore how our expertise could add value to your product, or for an initial discussion about partnering with us, please contact our team.

Get in touch

UK

Galen Limited
Seagoe Industrial Estate
Craigavon
BT63 5UA
United Kingdom

Telephone:+44 (0)28 3833 4974

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Nordics

POA Pharma Scandinavia AB
Banevænget 13, 1.
3460 Birkerød
Denmark

Telephone: +45 3117 4300

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Germany

POA Pharma GmbH
Langenbruchstraße 20A
D-45549 Sprockhövel
Germany

Telephone: +49 (0)2339 9113404

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.